ABSTRACT
BACKGROUND: Intellectual disability and patient activation may be important drivers of inequities in health service access and health outcomes for people with intellectual disability transitioning from prison to the community. We assessed the association between intellectual disability and patient activation after prison release and examined whether this association varied, depending on whether intellectual disability was identified prior to prison release. METHODS: Overall, 936 prisoners were screened for intellectual disability by using the Hayes Ability Screening Index and completed the Patient Activation Measure (PAM) within 6 weeks of prison release and again at 1, 3 and 6 months post-release. We estimated the association between intellectual disability status and PAM scores by using a multilevel linear model, adjusting for sociodemographic, behavioural, health and criminogenic factors. We used propensity score matching to estimate the impact of being identified with intellectual disability prior to release from prison on the change in mean PAM score after prison release. RESULTS: Compared with those who screened negative for intellectual disability, ex-prisoners who screened positive, both with and without prior identification of intellectual disability, had significantly decreased mean PAM scores [(B = -4.3; 95% CI: -6.3, -2.4) and (B = -4.5; 95% CI: -6.8, -2.3), respectively] over 6 months of follow-up. Among those who reported being identified with intellectual disability prior to release from prison, a significant increase in PAM score at the 6-month follow-up interview (B = 5.89; 95% CI: 2.35, 9.42; P = 0.001) was attributable to being identified with intellectual disability prior to release. CONCLUSIONS: Ex-prisoners screening positive for possible intellectual disability have decreased patient activation for at least 6 months after release from prison. However, individuals whose possible intellectual disability is unidentified appear to be particularly vulnerable. Incarceration is a pivotal opportunity for the identification of intellectual disability and for initiating transitional linkages to health and intellectual disability-specific community services for this marginalised population.
Subject(s)
Intellectual Disability/psychology , Patient Participation/psychology , Prisoners/psychology , Self-Management/psychology , Adult , Australia/epidemiology , Female , Humans , Intellectual Disability/epidemiology , Male , Patient Participation/statistics & numerical data , Prisoners/statistics & numerical data , Prospective Studies , Randomized Controlled Trials as Topic , Self-Management/statistics & numerical data , Young AdultABSTRACT
This prospective longitudinal study examined both short- and long-term changes in health-related quality of life (HRQL) in 52 breast cancer patients with poor prognosis receiving high-dose chemotherapy (HDC) treatment with autologous blood stem cell transplantation (ASCT). HRQL was measured seven times from baseline to 2 years post enrollment with the Functional Living Index-Cancer (FLIC), the EuroQol (EQ-5D), and a quality of life visual analogue scale. The percentage of questionnaires returned at each assessment time ranged from 80 to 92%. All three measures showed a similar pattern of change, with HRQL decreasing following administration of HDC, and returning to baseline levels 8 weeks post HDC. A repeated-measures analysis of variance showed that the FLIC at 2 years was significantly better than baseline (P=<0.0001). Difficulty sleeping, headaches, and decreased sexual interest were the most common symptoms reported in the longer term. Our results have implications for early psychosocial intervention in the care of breast cancer patients with poor prognosis undergoing treatment with HDC and ASCT because such interventions can further improve the quality of their survival.
Subject(s)
Breast Neoplasms/psychology , Breast Neoplasms/therapy , Stem Cell Transplantation/methods , Adult , Analysis of Variance , Antineoplastic Combined Chemotherapy Protocols , Breast Neoplasms/diagnosis , Clinical Trials as Topic , Cyclophosphamide/pharmacology , Female , Follow-Up Studies , Humans , Longitudinal Studies , Middle Aged , Mitoxantrone/pharmacology , Prognosis , Prospective Studies , Quality of Life , Time Factors , Transplantation, Autologous , Treatment Outcome , Vinblastine/pharmacologyABSTRACT
Physicians commonly recommend estrogen replacement as treatment for exercise-associated amenorrhoea. While the evidence shows that the basis of the amenorrhoea is estrogen deficiency, it is not clear that it is the only factor in the development of lowered bone density found in oligo-amenorrhoeic female athletes. Nutritional factors, significant in the development of the reproductive dysfunction, could also contribute to bone loss. No randomised, controlled studies of estrogen replacement in athletes have been published. However, one nonrandomised study of a small group of athletes does suggest that there are significant gains in bone density to be made by the initiation of estrogen therapy. More research is clearly needed.
Subject(s)
Amenorrhea/drug therapy , Amenorrhea/etiology , Estrogen Replacement Therapy , Estrogens/deficiency , Exercise , Sports , Amenorrhea/complications , Body Composition , Bone Density/drug effects , Cardiovascular Diseases/etiology , Estrogens/pharmacology , Female , Humans , Infertility/etiology , Nutritional Status , Osteoporosis/etiology , Osteoporosis/prevention & control , Recovery of FunctionABSTRACT
Clinical studies have traditionally identified treatment-specific side effects by comparison of voiced side effects in treatment and placebo arms of a study. Highly motivated women in a clinical trial may underreport drug-induced symptoms for medications which may be considered lifesaving. Affective symptoms during treatment of early breast cancer with tamoxifen (an estradiol receptor antagonist) were reported as infrequent by the manufacturer. However, reports suggest a higher rate of depression during general use. The objective of the present study was to examine the frequency of symptoms that might be side effects of tamoxifen and to relate them to the way the women attributed such symptoms. The exploratory study involved semistructured telephone interviews of 25 women who were taking tamoxifen. Textual analysis of the information was used to examine the symptoms described by the women. They were also asked whether any symptoms were related to the medication. The symptoms and their attribution were evaluated against a background of self-perceived stress. The principal finding was a pattern of ambivalence in attributing symptoms to the drug. Of all the symptomatic changes noted, the women only attributed 51% to tamoxifen. Flushes, fatigue, and depression were reported most frequently during treatment; flushes were readily attributed to tamoxifen but depression and fatigue were attributed to another factor by half of the symptomatic women. Women who reported moderate to high levels of life stress were less likely to attribute symptoms to drug therapy. The results suggest that women taking tamoxifen may not attribute known drug side effects to use of the medication.
Subject(s)
Breast Neoplasms/prevention & control , Estrogen Antagonists/adverse effects , Tamoxifen/adverse effects , Aged , Depression/chemically induced , Female , Hot Flashes/chemically induced , HumansABSTRACT
OBJECTIVE: To assess the responsiveness of the EuroQol (EQ-5D) by comparing it with the Functional Living Index-Cancer (FLIC) and a self-reported rating of health-related quality of life (HRQL). METHODS: HRQL was measured four times during the course of high dose chemotherapy (HDC) and bone marrow transplantation in 40 patients with stage II and III breast cancer. Measurements were at baseline (T1), pre-HDC (T2), 3 weeks post-HDC (T3), and 3 months post-HDC (T4). RESULTS: Effect size ranged from 1.16 (T1-T3) to 0.66 (T3-T4) for the EQ-5D and 0.85-0.91 respectively for the FLIC. No significant differences in effect sizes between the EQ-5D and the FLIC were found. Repeated measures ANOVA yielded a significant change for all measures, with HRQL decreasing post-HDC and returning to baseline levels by 3 m post-HDC. EQ-5D dimensions changed significantly over time for mobility, self-care, and usual activities. EQ-5D index scores at T3 had a bimodal distribution. Interpretation of psychological changes was facilitated by an analysis of FLIC items. CONCLUSIONS: The EQ-5D is responsive to the clinically large changes associated with HDC in breast cancer patients. The bimodal distribution of the EQ-5D index has implications for the interpretation of EQ-5D change scores.
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Breast Neoplasms/physiopathology , Quality of Life , Sickness Impact Profile , Alberta , Analysis of Variance , Bone Marrow Transplantation , Breast Neoplasms/psychology , Breast Neoplasms/therapy , Combined Modality Therapy , Dose-Response Relationship, Drug , Female , Health Services Research , Humans , Longitudinal Studies , Prospective Studies , Self Efficacy , Surveys and QuestionnairesABSTRACT
OBJECTIVE: To determine whether differences existed in mood and coping styles among fertile men, oligoasthenospermic men, or euspermic men whose wives were undergoing ovulation stimulation with clomiphene and IUI. DESIGN: A cross-sectional research design. SETTING: Hospital-based academic fertility clinic. PATIENT(S): 30 fertile men with currently pregnant wives, 30 euspermic and 30 oligoasthenospermic men in couples undergoing ovulation stimulation with clomiphene and IUI. INTERVENTION(S): Measures of psychological well-being and coping were administered. MAIN OUTCOME MEASURE(S): Biodemographic information, and psychometric measures of mood and coping. RESULT(S): There were no significant differences among the groups on any of the measures except the Family Inventory of Life Events (FILE), in which fertile men reported higher stress levels. FILE scores in all groups were moderate, indicating typical levels of family stress. CONCLUSION(S): Mood and coping in the three groups were similar. This study suggests that men's psychological adjustment to their own infertility and to unexplained infertility is generally healthy.
Subject(s)
Adaptation, Psychological/physiology , Affect , Infertility, Male/psychology , Adult , Anger , Anxiety , Clomiphene/therapeutic use , Cross-Sectional Studies , Family , Female , Fertility Agents, Female/therapeutic use , Humans , Informed Consent , Male , Ovulation Induction , Pregnancy , Self ConceptABSTRACT
Sociability and irritability are commonly cited symptoms of premenstrual syndrome but there has been little investigation of these cycle related changes using clearly defined test instruments. We examined the two symptoms using symptom specific subscales from the Multiscore Depression Inventory (Berndt, 1983). Clear and consistent cycle related changes in irritability and sociability were seen in 20 women with prospectively validated symptomatic premenstrual change but not in a control group of 8 women without symptomatic premenstrual change. The study suggests that these variables can be measured using specific brief scales.
Subject(s)
Interpersonal Relations , Irritable Mood/physiology , Premenstrual Syndrome/psychology , Adult , Female , Humans , Middle Aged , Premenstrual Syndrome/diagnosis , Premenstrual Syndrome/physiopathology , Psychiatric Status Rating Scales , Reference Values , Sensitivity and SpecificityABSTRACT
To obtain information about the psychological needs of wheelchair users, 45 subjects participating in a university-based drop-in physical activity centre and outpatient rehabilitation program completed the Personal Styles Inventory and the Ways of Coping Inventory. Three groups of subjects were formed, differentiated by etiology for their disability. Results suggested that subjects with brain injury possessed the most limited coping resources. Subjects with multiple sclerosis were highest of the three groups in the frequency of utilization of emotional coping, they also revealed a fundamentally introverted and stability-based personality style. Subjects with spinal cord injuries utilized a predominantly Problem-solving means of coping: and they revealed a basic personality style characterized as extroverted and stable. The findings suggest that disease process (perhaps through common preexisting psychological characteristics, the nature of the onset and progression of the disease process, and/or tissue damage) may modify the ability to adapt and cope with the need to use a wheelchair. The nature of psychological support to be offered should reflect not only the use of a wheelchair but also the underlying personality and its modification by the nature of the disease process.
Subject(s)
Adaptation, Psychological , Paraplegia/psychology , Wheelchairs , Adult , Brain Injuries/complications , Cognition/physiology , Emotions/physiology , Female , Humans , Male , Multiple Sclerosis/complications , Multivariate Analysis , Paraplegia/etiology , Paraplegia/rehabilitation , Personality , Self-Assessment , Spinal Cord Injuries/complicationsABSTRACT
The frequency with which families have to deal with cancer death is increasing as the population ages. The prevalence of some cancers in younger people is also increasing. In this article the authors focus on helping families deal with the anticipated cancer death of a family member. The article includes a definition of those groups of people who form families in the 1990s and examines dimensions along which families vary such as belief systems. We discuss the needs of families when a family member has a terminal cancer diagnosis and outline coping strategies that are seen in families and ways in which nurses and other health care professionals can facilitate adaptive coping.
Subject(s)
Adaptation, Psychological , Family/psychology , Long-Term Care/psychology , Neoplasms/psychology , Terminal Care/psychology , Health Services Needs and Demand , Humans , Neoplasms/nursingABSTRACT
To determine whether women seeking treatment for symptomatic premenstrual change have ongoing psychological disturbance, we undertook a cross-sectional, comparative study across four groups of reproductive-age women. Subjects were 35 patients with symptomatic premenstrual change and no psychiatric history, 35 women without symptomatic premenstrual change, 35 patients with affective disorders, and 35 women from the community at large. All women except those in the community sample were tested in the intermenstrual phase (after menses but before the 12th cycle day). Psychological tests administered were Profile of Mood States, State-Trait Anxiety Inventory, Institute for Personality and Ability Testing (IPAT) Anxiety Scale, IPAT Depression Scale, General Health Questionnaire and the Family Inventory of Life Events (FILE). Demographic data and information concerning present and past stresses were also collected. Women with symptomatic premenstrual change were distinguishable from psychiatric patients on assessment of intermenstrual mood state. They were no different from women within the community at large or from non-symptomatic women. When symptomatic women reported on time periods, which include the premenstrual phase of the cycle, we found results at variance with those obtained in relation to current state mood. While not unlike the women from the community at large in longer term affective characteristics, they were consistently different from non-symptomatic women and sometimes indistinguishable from psychiatric patients. Women with symptomatic premenstrual change also reported higher levels of past external stresses than women taken from the community at large.
Subject(s)
Mood Disorders/diagnosis , Premenstrual Syndrome/psychology , Women/psychology , Adult , Anxiety/diagnosis , Cross-Sectional Studies , Female , Hospitalization , Humans , Middle Aged , Mood Disorders/rehabilitation , Psychiatric Status Rating Scales , Stress, Psychological , Women's HealthABSTRACT
Cytomegalovirus is an important pathogen in persons infected with human immunodeficiency virus. In this study a thorough oral examination was done and blood and urine cultures for cytomegalovirus were obtained from a group of 31 patients with acquired immunodeficiency syndrome with CD4 lymphocyte counts less than 150 cells/mm3. Whole saliva was also collected for detection of cytomegalovirus deoxyribonucleic acid (DNA) via the polymerase chain reaction. The presence of cytomegalovirus DNA in the saliva specimens was not related to the presence of cytomegalovirus in the urine, which suggests a local source of cytomegalovirus from salivary gland and kidney parenchyma. There was also a strong statistical relationship between salivary cytomegalovirus DNA and xerostomia (p = 0.0004), which suggests that cytomegalovirus may be a cause of salivary gland dysfunction in patients with acquired immunodeficiency syndrome with low CD4 counts.
Subject(s)
Acquired Immunodeficiency Syndrome/complications , Cytomegalovirus Infections/etiology , Saliva/virology , Xerostomia/virology , Adult , CD4 Lymphocyte Count , Cytomegalovirus/isolation & purification , DNA, Viral/analysis , Female , Humans , Male , Middle Aged , Pilot Projects , Polymerase Chain Reaction , Urine/microbiology , Virus Cultivation , Virus Shedding , Xerostomia/etiologyABSTRACT
Fluid intake was measured at 3 phases of the menstrual cycle in twenty women with prospectively validated premenstrual syndrome and 8 women with prospectively validated absence of cyclic symptoms. There was no cycle related change in fluid intake in either group but fluid intake was significantly lower in women with PMS than in controls at all phases of the menstrual cycle. All subjects but one denied voluntary fluid restriction. The mechanism, therefore, appears subconscious and may be related to perceived increase in fluid retention.
Subject(s)
Drinking Behavior , Drinking , Premenstrual Syndrome/psychology , Water-Electrolyte Balance , Adult , Case-Control Studies , Drinking/physiology , Drinking Behavior/physiology , Female , Humans , Middle Aged , Premenstrual Syndrome/physiopathology , Prospective Studies , Water-Electrolyte Balance/physiologyABSTRACT
Textual analysis was used to examine responses to an open ended question about women's experiences of premenstrual change. The question was the final item of the Premenstrual Assessment Form (PAF), a retrospective PMS questionnaire. Of the 336 women who answered the PAF, 261 provided a written narrative summary. We found a logical hierarchy of distinctions covering the presence or absence of changes, their timing, and attributive aspects, and a final cumulative distinction in which women provided information about the consequences of their premenstrual change. Although attribute aspects mirrored the PAF, distinctions in timing and in the cumulative effect of changes differed. The analysis suggests that questionnaires could be designed which more precisely reflect premenstrual change.
Subject(s)
Data Collection/standards , Premenstrual Syndrome/psychology , Semantics , Adult , Data Collection/methods , Discrimination, Psychological , Emotions , Female , Humans , Middle Aged , Premenstrual Syndrome/physiopathology , Self-Assessment , Surveys and Questionnaires , Time FactorsABSTRACT
Langerhans cells (LC) serve as antigen presenting cells and provide immune surveillance within epithelia. Since depression of LC number and/or function may allow tolerance to antigens, we evaluated LC in median rhomboid glossitis (MRG), a condition linked to persistent candidal infection of lingual mucosa. Material included a total of 36 cases of MRG (7 of which did not show PAS + fungi) and 6 controls. LC were identified by their expression of S-100 and HLA-DR antigens and quantified using image analysis. Equal numbers of LC were identified using S-100 + and HLA-DR + markers. The density of LC (cells/mm of basement membrane, mean +/- SD) in both PAS + MRG (2.6 +/- 1.3) and PAS-MRG (3.0 +/- 1.7) was markedly depressed compared with controls (17.2 +/- 6.4), (P less than 0.001). These findings indicate that the LC network is perturbed in MRG, and are consistent with the view that of localized defect in immune surveillance may contribute to persistent fungal infection of the oral mucosa.
Subject(s)
Glossitis/pathology , Langerhans Cells/pathology , Tongue/cytology , Candidiasis, Oral/pathology , Cell Count , Dihydroxyphenylalanine/metabolism , HLA-DR Antigens/analysis , Humans , Immunoenzyme Techniques , Immunophenotyping , Langerhans Cells/chemistry , Langerhans Cells/metabolism , Melanocytes/metabolism , Melanocytes/pathology , Middle Aged , Retrospective Studies , S100 Proteins/analysis , Tongue Diseases/pathologyABSTRACT
The discouraging results of early efforts to educate the public about sexually transmitted diseases indicated that the goals of STD preventive action must be longer term and must change attitudes and behaviour as well as educate. They must also avoid an ostrich mentality about the sexual involvement of young people. This article examines more recent approaches to teaching about sexuality in general and STD prevention in particular.